Halozyme Therapeutics shares owned by Arbor Investment Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Arbor Investment Advisors
from 13F filings
Historical chart of Arbor Investment Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Arbor Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics by Arbor Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $1.0M | 18k | 57.24 |
2024-03-31 | $730k | 18k | 40.68 |
2023-12-31 | $663k | 18k | 36.96 |
2023-09-30 | $686k | 18k | 38.20 |
2023-06-30 | $648k | 18k | 36.07 |
2023-03-31 | $686k | 18k | 38.19 |
2022-12-31 | $1.0M | 18k | 56.90 |
2022-06-30 | $790k | 18k | 44.01 |
2022-03-31 | $716k | 18k | 39.89 |
2021-12-31 | $722k | 18k | 40.22 |
2021-09-30 | $730k | 18k | 40.67 |
2021-06-30 | $815k | 18k | 45.40 |
2021-03-31 | $748k | 18k | 41.67 |
2020-12-31 | $767k | 18k | 42.73 |
2020-09-30 | $472k | 18k | 26.30 |
2020-06-30 | $481k | 18k | 26.80 |
2020-03-31 | $323k | 18k | 17.99 |
2019-12-31 | $318k | 18k | 17.72 |
2019-09-30 | $278k | 18k | 15.49 |
2019-06-30 | $308k | 18k | 17.16 |